Citation Impact
Citing Papers
Rodent-borne diseases and their risks for public health
2009 Standout
Hantaviruses: Immunology, Treatment, and Prevention
2004
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Structures and mechanisms in flavivirus fusion
2000
Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge
2006
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
2003
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
2005
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Hantavirus pulmonary syndrome
2011
A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies
2005
Lipid nanoparticles for mRNA delivery
2021 Standout
Duration of antiviral immunity after smallpox vaccination
2003 Standout
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Rapid and sensitive immunomagnetic-electrochemiluminescent detection of staphyloccocal enterotoxin B
2000
Hantavirus Pulmonary Syndrome: The New American Hemorrhagic Fever
2002
Structure of Dengue Virus
2002 Standout
Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus
2010
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Dengue: a continuing global threat
2010 Standout
Treatment of hantavirus pulmonary syndrome
2007
Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis
2020 Standout
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
2011 StandoutNature
Advances in Virus-Like Particle Vaccines for Filoviruses
2011
Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix
2009 Standout
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin
2005
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
1999
THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
1999
Ebola Virus‐Like Particle–Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge
2007
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120
2004 StandoutNobel
Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and japanese encephalitis virus
2003
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Microneedles for drug and vaccine delivery
2012 Standout
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
New Vaccine Technologies to Combat Outbreak Situations
2018
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice
2019
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Ebola virus: from discovery to vaccine
2003
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
2004
Tick-borne encephalitis
2003
Immune responses to DNA vaccines
1999
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
Immune Recognition of Foreign DNA
1999
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
DNA Vaccines: Recent Developments and Future Possibilities
2006
Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine
2008
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion
2015
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses
2001
Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein
2001
Elevated Generation of Reactive Oxygen/Nitrogen Species in Hantavirus Cardiopulmonary Syndrome
2002
Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis Virus
2005
Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5
2009
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice
2003
Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement
2008
West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays
2001
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Kinetics of Immune Responses in Deer Mice Experimentally Infected with Sin Nombre Virus
2012
Electrochemiluminescence (ECL)
2004 Standout
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques
2006
Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
2013
Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions
2002
The mechanochemical basis of cell and tissue regulation.
2004
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
2006 StandoutNobel
Influences of Glycosylation on Antigenicity, Immunogenicity, and Protective Efficacy of Ebola Virus GP DNA Vaccines
2006
Transmission Study of Andes Hantavirus Infection in Wild Sigmodontine Rodents
2004
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination
2008
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
1999
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
2008
C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1
2012 StandoutNobel
Ebola virus-like particles protect from lethal Ebola virus infection
2003
Correlates of Protection Induced by Vaccination
2010 Standout
The gene gun: current applications in cutaneous gene therapy
2000
Works of David Custer being referenced
DNA Vaccination with Hantavirus M Segment Elicits Neutralizing Antibodies and Protects against Seoul Virus Infection
1999
Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates
2003
Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates
2005
DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge
1998
A Lethal Disease Model for Hantavirus Pulmonary Syndrome
2001
DNA Vaccination with Vaccinia Virus L1R and A33R Genes Protects Mice against a Lethal Poxvirus Challenge
2000
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
2003
Evaluation of Tick-Borne Encephalitis DNA Vaccines in Monkeys
1999
Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge
1997
DNA Vaccination with the Hantaan Virus M Gene Protects Hamsters against Three of Four HFRS Hantaviruses and Elicits a High-Titer Neutralizing Antibody Response in Rhesus Monkeys
2001
Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine
2003